Literature DB >> 8022404

The marked disparity between the sizes of angiotensin type 2 receptors from different tissues is related to different degrees of N-glycosylation.

G Servant1, D T Dudley, E Escher, G Guillemette.   

Abstract

We recently described the photoaffinity labeling and partial characterization of the angiotensin type 2 (AT2) receptor from human myometrium. In the present study, specific receptors for angiotensin II (AII) were also analyzed in a murine fibroblast cell line (R3T3) and a rat pheochromocytoma cell line (PC-12). Dose-displacement experiments with PD 123319 (an AT2-selective antagonist) completely inhibited 125I-AII binding, whereas L-158,809 (an AT1-selective antagonist) had no significant effect on 125I-AII binding, thus revealing that these two cell lines express exclusively AT2 sites. High yields of covalent and selective labelling of AT2 receptors from human myometrium, R3T3 cells, and PC-12 cells were obtained with the photosensitive analogue 125I-[Sar1,Val5,p-benzoyl-Phe8]AII. Gel permeation chromatography of Triton X-100-solubilized AT2 receptors from the three different sources revealed similar Stokes' radii of about 65 A. Interestingly, upon electrophoresis under reducing conditions, marked disparities were observed between the apparent molecular masses of AT2 receptors from the three different sources. As observed previously, AT2 receptors from human myometrium showed a molecular mass of 68 +/- 4.6 kDa. AT2 receptors from PC-12 cells showed a larger molecular mass of 113 +/- 12 kDa, whereas AT2 receptors from R3T3 cells showed a molecular mass of 91 +/- 7.8 kDa. After endoglycosidase digestion with an enzyme that cleaves N-linked saccharides, the molecular masses of the denatured AT2 receptors of human myometrium, R3T3 cells, and PC-12 cells were decreased by 54%, 66%, and 73%, to 31.3 +/- 1.6 kDa, 30.9 +/- 0.7 kDa, and 30.6 +/- 0.8 kDa, respectively. Kinetic studies with AT2 receptors from human myometrium revealed a complex, multiple-step process of deglycosylation involving at least three different sites of N-linked saccharides. These results suggest that the disparity in the sizes of AT2 receptors from different sources is mostly related to different degrees of N-glycosylation. They also imply that the AT2 receptor contains at least three asparagine-linked sites of glycosylation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8022404

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  11 in total

1.  Pharmacological characterization of angiotensin II AT(2) receptor subtype heterogeneity in the rat adrenal cortex and medulla.

Authors:  X Lu; K L Grove; W Zhang; R C Speth
Journal:  Endocrine       Date:  1995-04       Impact factor: 3.633

2.  N-glycosylation requirements for the AT1a angiotensin II receptor delivery to the plasma membrane.

Authors:  B Deslauriers; C Ponce; C Lombard; R Larguier; J C Bonnafous; J Marie
Journal:  Biochem J       Date:  1999-04-15       Impact factor: 3.857

3.  Ontogeny of angiotensin type 2 and type 1 receptor expression in mice.

Authors:  Juan Gao; Jie Chao; Karma-Jaya K Parbhu; Li Yu; Liang Xiao; Fei Gao; Lie Gao
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2012-04-22       Impact factor: 1.636

4.  Analysis of the role of N-glycosylation in cell-surface expression and binding properties of angiotensin II type-2 receptor of rat pheochromocytoma cells.

Authors:  G Servant; D T Dudley; E Escher; G Guillemette
Journal:  Biochem J       Date:  1996-01-01       Impact factor: 3.857

5.  Tissue-specific renin-angiotensin system in pulmonary lymphangioleiomyomatosis.

Authors:  Julio C Valencia; Gustavo Pacheco-Rodriguez; Adriana K Carmona; Janina Xavier; Patrick Bruneval; William K Riemenschneider; Yoshihiko Ikeda; Zu-Xi Yu; Victor J Ferrans; Joel Moss
Journal:  Am J Respir Cell Mol Biol       Date:  2006-02-10       Impact factor: 6.914

6.  Immunohistochemical detection of angiotensin II receptors in mouse cerebellum and adrenal gland using "in vivo cryotechnique".

Authors:  Zheng Huang; Nobuhiko Ohno; Nobuo Terada; Yurika Saitoh; Jiaorong Chen; Shinichi Ohno
Journal:  Histochem Cell Biol       Date:  2013-03-21       Impact factor: 4.304

7.  Impact of cell type and epitope tagging on heterologous expression of G protein-coupled receptor: a systematic study on angiotensin type II receptor.

Authors:  Lili Jiang; Gladys M K Teng; Elaine Y M Chan; Shannon W N Au; Helen Wise; Susanna S T Lee; Wing-Tai Cheung
Journal:  PLoS One       Date:  2012-10-08       Impact factor: 3.240

8.  Maternal nutrient restriction and the fetal left ventricle: decreased angiotensin receptor expression.

Authors:  Jeffrey S Gilbert; Alvin L Lang; Mark J Nijland
Journal:  Reprod Biol Endocrinol       Date:  2005-07-14       Impact factor: 5.211

9.  Commercially available angiotensin II At₂ receptor antibodies are nonspecific.

Authors:  Roman Hafko; Sonia Villapol; Regina Nostramo; Aviva Symes; Esther L Sabban; Tadashi Inagami; Juan M Saavedra
Journal:  PLoS One       Date:  2013-07-01       Impact factor: 3.240

10.  Angiotensin II type 2 receptor (AT2 R) localization and antagonist-mediated inhibition of capsaicin responses and neurite outgrowth in human and rat sensory neurons.

Authors:  U Anand; P Facer; Y Yiangou; M Sinisi; M Fox; T McCarthy; C Bountra; Y E Korchev; P Anand
Journal:  Eur J Pain       Date:  2012-12-17       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.